@article{Yao2026, 
author = {Yanzhu Yao and Yuyan Wang and Shuai Mao and Yuqi Liu and Yunzhang Zhao and Yifan Wang and Chao Lyu and Tong Yin},
title = {Correlation between platelet-derived hsa_circ_0001535 and antiplatelet reactivity in patients with acute coronary syndrome after dual anti-platelet therapy},
year = {2026},
journal = {Chinese Journal of Multiple Organ Diseases in the Elderly},
volume = {25},
number = {1},
pages = {1-6},
keywords = {acute coronary syndrome, platelet, hsa_circ_0001535, antiplatelet reactivity},
url = {https://www.sciopen.com/article/10.11915/j.issn.1671-5403.2026.01.001},
doi = {10.11915/j.issn.1671-5403.2026.01.001},
abstract = {ObjectiveTo investigate the expression of platelet-derived circular RNA hsa_circ_0001535 and to analyze its correlation with antiplatelet reactivity in patients with acute coronary syndrome (ACS) after dual antiplatelet therapy.MethodsA total of 169 consecutive ACS patients hospitalized in the Department of Cardiology of Chinese PLA General Hospital between October 2020 and March 2022 and treated with aspirin combined with a P2Y12 receptor antagonist were enrolled. All patients underwent thromboelastography (TEG) after receiving a single dose of dual antiplatelet therapy. Adenosine diphosphate (ADP)-induced platelet-fibrin clot strength (MAADP) of platelet-fibrin clot strength and ADP-induced platelet inhibition rate (PIADP) were used to reflect antiplatelet reactivity. With PIADP 75% as the cutoff value, patients were divided into a low on-treatment platelet reactivity group (LTPR group, n=106, PIADP &gt;75%) and a high on-treatment platelet reactivity group (HTPR group, n=63, PIADP≤ 75%). Platelet RNA was extracted from peripheral whole blood, and the relative expression level of hsa_circ_0001535 in platelets was detected by fluorescent quantitative multiplex polymerase chain reaction (PCR). Data analysis was performed using SPSS 27.0 and R language version 4.4.2. Based on data type, intergroup comparisons were conducted using the t-test, Wilcoxon rank-sum test, or χ2 test. Multivariate logistic regression analysis revealed that age (OR=1.07, 95%CI 1.02-1.13; P=0.0071), body mass index (OR=0.82, 95%CI 0.72-0.94; P=0.0030), platelet-derived hsa_circ_0001535 (OR=1.22, 95%CI 1.04-1.43; P=0.0160), clopidogrel (OR=2.45, 95%CI 1.12-5.35; P=0.0242), and CYP2C19 loss-of-function (OR=1.24, 95%CI 1.01-1.51; P=0.0421) were independent factors affecting antiplatelet reactivity after dual antiplatelet therapy in ACS patients.ResultsIn the 169 patients, the median relative expression level of platelet-derived hsa_circ_0001535 was 1.47 (0.83, 2.66), the median MAADP was 19.40 (10.63, 31.18), and the median PIADP was 88.20% (55.04%, 94.55%), all showing a skewed distribution. Spearman correlation analysis found that the relative expression level of platelet-derived hsa_circ_0001535 was negatively correlated with PIADP (r=-0.16, P=0.039). The expression level of platelet-derived hsa_circ_0001535 was significantly higher in the HTPR group than that in the LTPR group [1.94 (1.15, 3.76) vs. 1.28 (0.59, 2.14); P=0.0006)]. Multivariate logistic regression analysis revealed that platelet-derived hsa_circ_0001535 was an independent factor affecting antiplatelet reactivity after dual antiplatelet therapy in ACS patients (OR=1.22, 95%CI 1.04-1.43; P=0.0160).ConclusionThe relative expression level of platelet-derived hsa_circ_0001535 is independently correlated with antiplatelet reactivity in ACS patients after dual antiplatelet therapy.}
}